Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,122,649
-
Share change
-
+3,060,582
-
Total reported value
-
$34,471,000
-
Price per share
-
$3.10
-
Number of holders
-
20
-
Value change
-
+$9,402,673
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) as of Q4 2016
As of 31 Dec 2016,
VBI VACCINES INC CDA - COM NEW (VBIV) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,122,649 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Clarus Ventures, LLC, Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, BANK OF MONTREAL /CAN/, TWIN FOCUS CAPITAL PARTNERS, LLC, GEODE CAPITAL MANAGEMENT, LLC, and ROYAL BANK OF CANADA.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.